AARTIDRUGS — Aarti Drugs Balance Sheet
0.000.00%
- IN₹35.59bn
- IN₹41.12bn
- IN₹25.65bn
Annual balance sheet for Aarti Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 342 | 197 | 198 | 216 | 243 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 8,325 | 8,659 | 7,052 | 7,624 | 8,306 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 13,934 | 14,918 | 13,207 | 13,384 | 14,678 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,665 | 8,622 | 10,351 | 11,331 | 12,838 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 22,080 | 24,214 | 24,324 | 25,747 | 28,153 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9,401 | 9,495 | 7,955 | 8,370 | 9,223 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 11,716 | 12,290 | 11,508 | 12,057 | 12,664 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 10,364 | 11,924 | 12,815 | 13,690 | 15,489 |
| Total Liabilities & Shareholders' Equity | 22,080 | 24,214 | 24,324 | 25,747 | 28,153 |
| Total Common Shares Outstanding |